Cargando…
FGF9 promotes cisplatin resistance in colorectal cancer via regulation of Wnt/β-catenin signaling pathway
Development of cisplatin resistance in colorectal cancer is largely caused by dysregulation of signaling pathways, including the Wnt/β-catenin signaling pathway, in cancer cells. Further investigation into the molecular mechanism of chemoresistance could improve outcomes for patients with colorectal...
Autores principales: | Zhang, Zhijin, Zhang, Yuhao, Qin, Xinju, Wang, Yuexia, Fu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026987/ https://www.ncbi.nlm.nih.gov/pubmed/32104224 http://dx.doi.org/10.3892/etm.2019.8399 |
Ejemplares similares
-
KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer
por: Yao, Hanhui, et al.
Publicado: (2022) -
Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway
por: Wang, Xi, et al.
Publicado: (2020) -
CircNOL10 Acts as a Sponge of miR-135a/b-5p in Suppressing Colorectal Cancer Progression via Regulating KLF9
por: Zhang, Yuhao, et al.
Publicado: (2020) -
FGF9 Promotes Expression of HAS2 in Palatal Elevation via the Wnt/β-Catenin/TCF7L2 Pathway
por: Sun, Yidan, et al.
Publicado: (2022) -
HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway
por: Zhang, Zheying, et al.
Publicado: (2017)